Current price is more than the intrinsic value

Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Suven Pharmaceuticals standalone net profit declines 31.49% in the September 2022 quarter

V I P Industries Ltd, Suven Pharmaceuticals Ltd, EIH Ltd and Sun Pharma Advanced Research Company Ltd are among the other losers in the BSE’s ‘A’ group today, 04 October 2022.

Ahluwalia Contracts (India) Ltd leads losers in ‘A’ group

Suven Pharmaceuticals announced that Casper Parma, its wholly owned subsidiary has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) after the pre-approval inspection at a facility.

Suven Pharma facility gets EIR from USFDA

The pre-approval inspection was conducted between July 25 to July 29, 2022.

USFDA issues EIR for Suven Pharmaceuticals’ subsidiary; stock skids ~2%

Suven Pharmaceuticals Ltd is a mid-cap company having a market cap of ₹12,504.23 Crore operating in the pharma sector

This multibagger stock shall pay 600% dividend soon: Do you own it?

NELCO Ltd, Aegis Logistics Ltd, Surya Roshni Ltd and Suven Pharmaceuticals Ltd are among the other gainers in the BSE’s ‘A’ group today, 29 August 2022.

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

The US Food and Drug Administration (USFDA) completed a pre-approval inspection at Casper Pharma formulations manufacturing facility situated at GMR Hyderabad SEZ.

Suven Pharma says Casper Pharma completes USFDA pre-approval inspection

Broker’s call: Suven Pharma (Accumulate)

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Suven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 13147.01 Crore) operating in Pharmaceuticals sector.

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharmaceuticals Limited is an India-based company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharmaceuticals standalone net profit declines 31.49% in the September 2022 quarter

Ahluwalia Contracts (India) Ltd leads losers in ‘A’ group

Suven Pharma facility gets EIR from USFDA

USFDA issues EIR for Suven Pharmaceuticals’ subsidiary; stock skids ~2%

This multibagger stock shall pay 600% dividend soon: Do you own it?

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

Suven Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharmaceuticals standalone net profit declines 31.49% in the September 2022 quarter

Ahluwalia Contracts (India) Ltd leads losers in ‘A’ group

Suven Pharma facility gets EIR from USFDA

USFDA issues EIR for Suven Pharmaceuticals’ subsidiary; stock skids ~2%

This multibagger stock shall pay 600% dividend soon: Do you own it?

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock